ArticleContemporary oncology (Poznan, Poland)2016

Synergistic effects of sorafenib in combination with gemcitabine or pemetrexed in lung cancer cell lines with K-ras mutations.

Jing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.